BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15675623)

  • 1. [Multiorgan resection in patients with gastric cancer].
    Radovanović D; Stevanović D; Pavlović I; Bajec A; Vekić B; Mitrović N
    Med Pregl; 2004; 57(9-10):480-6. PubMed ID: 15675623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of systematic lymphadenectomy on length of survival in patients with gastric carcinoma].
    Stevanović D; Radovanović D; Pavlović I; Kostić P
    Med Pregl; 2004; 57(3-4):175-80. PubMed ID: 15462604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of gastric cancer. 'Real' 5-year survival rates and mortality rates in a country with high incidence.
    Cenitagoya GF; Bergh CK; Klinger-Roitman J
    Dig Surg; 1998; 15(4):317-22. PubMed ID: 9845606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early postoperative complications and risk factors in laparoscopic D2 radical gastrectomy for gastric cancer].
    Cai M; Zeng XY; Xiong Z; Gao JB; Shuai XM; Cai KL; Wang JL; Wang Z; Zhang P; Liu XH; Bai J; Cheng J; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):742-747. PubMed ID: 31422612
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of systematic lymphadenectomy on postoperative mortality and morbidity in patients with gastric cancer].
    Stevanović D; Radovanović D; Pavlović I; Mitrović N
    Med Pregl; 2004; 57(7-8):381-5. PubMed ID: 15626297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic D2 Lymph Node Dissection During Distal Subtotal Gastrectomy for Gastric Cancer: Toward Procedural Standardization.
    Kim YM; Son T; Kim HI; Noh SH; Hyung WJ
    Ann Surg Oncol; 2016 Aug; 23(8):2409-10. PubMed ID: 26957501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node dissection in resectable advanced gastric cancer.
    de Steur WO; Dikken JL; Hartgrink HH
    Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility of No.8p lymphadenectomy for the patients with advanced gastric cancer].
    Ye Z; Zeng Y; Wei S; Wang Y; Lin Z; Lin Z; Chen X; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1129-1135. PubMed ID: 30370511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
    Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
    Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan.
    Lee WJ; Lee WC; Houng SJ; Shun CT; Houng RL; Lee PH; Chang KJ; Wei TC; Chen KM
    World J Surg; 1995; 19(5):707-13. PubMed ID: 7571667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].
    Chen L; Wei S; Ye Z; Wang Y; Zheng Q; Zhuo C; Xiao J; Zeng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):67-72. PubMed ID: 28105623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.